Dr. Wesley Crouch, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 N Main St, Ephraim, UT 84627 Phone: 435-283-8194 |
Jessica Bradshaw, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 N Main St, Ephraim, UT 84627 Phone: 435-283-8194 Fax: 435-283-8205 |
Mr. James Darrell Fullmer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 475 S Main St, Ephraim, UT 84627 Phone: 435-283-0340 |
Kimberli C. Russell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 N Main St, Ephraim, UT 84627 Phone: 435-283-8194 |
Mr. Nathan Green Bridges Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 N Main St, 777 N Main, Ephraim, UT 84627 Phone: 435-283-8194 Fax: 435-283-8205 |
Suzanne Howell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 N Main St, Ephraim, UT 84627 Phone: 435-283-8189 |
News Archive
Changing how medication alerts are presented in electronic medical records resulted in safer prescribing, increased efficiency and reduced workload for health care providers who placed drug orders in a study published online in the Journal of the American Medical Informatics Association.
Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center. The findings could mean that identifying patients with poor quality of life could also identify patients with particularly aggressive tumors.
EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
› Verified 9 days ago